Cost-benefit performance simulation of robot-assisted thoracic surgery as required for financial viability under the 2016 revised reimbursement paradigm of the japanese national health insurance system

Naohiro Kajiwara, Yasufumi Kato, Masaru Hagiwara, Masatoshi Kakihana, Tatsuo Ohira, Norihiko Kawate, Norihiko Ikeda

    Research output: Contribution to journalArticle

    Abstract

    Purpose: To discuss the cost–benefit performance (CBP) and establish a medical fee system for robotic-assisted thoracic surgery (RATS) under the Japanese National Health Insurance System (JNHIS), which is a system not yet firmly established. Methods: All management steps for RATS are identical, such as preoperative and postoperative management. This study examines the CBP based on medical fees of RATS under the JNHIS introduced in 2016. Results: Robotic-assisted laparoscopic prostatectomy (RALP) and robotic-assisted partial nephrectomy (RAPN) now receive insurance reimbursement under the category of use of support devices for endoscopic surgery ($5420 and $3485, respectively). If the same standard amount were to be applied to RATS, institutions would need to perform at least 150 or 300 procedures thoracic operation per year to show a positive CBP ($317 per procedure as same of RALP and $130 per procedure as same of RAPN, respectively). Conclusion: Robotic surgery in some areas receives insurance reimbursement for its “supportive” use for endoscopic surgery as for RALP and RAPN. However, at present, it is necessary to perform da Vinci Surgical System Si (dVSi) surgery at least 150–300 times in a year in a given institution to prevent a deficit in income.

    Original languageEnglish
    Pages (from-to)73-80
    Number of pages8
    JournalAnnals of Thoracic and Cardiovascular Surgery
    Volume24
    Issue number2
    DOIs
    Publication statusPublished - 2018 Jan 1

    Fingerprint

    National Health Programs
    Robotics
    Thoracic Surgery
    Cost-Benefit Analysis
    Medical Fees
    Prostatectomy
    Nephrectomy
    Insurance
    Thorax
    Equipment and Supplies

    Keywords

    • Cost-Benefit performance
    • Da Vinci Surgical System
    • Japanese National Health Insurance System
    • Robot-assisted thoracic surgery

    ASJC Scopus subject areas

    • Surgery
    • Pulmonary and Respiratory Medicine
    • Cardiology and Cardiovascular Medicine
    • Gastroenterology

    Cite this

    Cost-benefit performance simulation of robot-assisted thoracic surgery as required for financial viability under the 2016 revised reimbursement paradigm of the japanese national health insurance system. / Kajiwara, Naohiro; Kato, Yasufumi; Hagiwara, Masaru; Kakihana, Masatoshi; Ohira, Tatsuo; Kawate, Norihiko; Ikeda, Norihiko.

    In: Annals of Thoracic and Cardiovascular Surgery, Vol. 24, No. 2, 01.01.2018, p. 73-80.

    Research output: Contribution to journalArticle

    @article{ae0de77f4fe7407795a22ed5b4b8bce9,
    title = "Cost-benefit performance simulation of robot-assisted thoracic surgery as required for financial viability under the 2016 revised reimbursement paradigm of the japanese national health insurance system",
    abstract = "Purpose: To discuss the cost–benefit performance (CBP) and establish a medical fee system for robotic-assisted thoracic surgery (RATS) under the Japanese National Health Insurance System (JNHIS), which is a system not yet firmly established. Methods: All management steps for RATS are identical, such as preoperative and postoperative management. This study examines the CBP based on medical fees of RATS under the JNHIS introduced in 2016. Results: Robotic-assisted laparoscopic prostatectomy (RALP) and robotic-assisted partial nephrectomy (RAPN) now receive insurance reimbursement under the category of use of support devices for endoscopic surgery ($5420 and $3485, respectively). If the same standard amount were to be applied to RATS, institutions would need to perform at least 150 or 300 procedures thoracic operation per year to show a positive CBP ($317 per procedure as same of RALP and $130 per procedure as same of RAPN, respectively). Conclusion: Robotic surgery in some areas receives insurance reimbursement for its “supportive” use for endoscopic surgery as for RALP and RAPN. However, at present, it is necessary to perform da Vinci Surgical System Si (dVSi) surgery at least 150–300 times in a year in a given institution to prevent a deficit in income.",
    keywords = "Cost-Benefit performance, Da Vinci Surgical System, Japanese National Health Insurance System, Robot-assisted thoracic surgery",
    author = "Naohiro Kajiwara and Yasufumi Kato and Masaru Hagiwara and Masatoshi Kakihana and Tatsuo Ohira and Norihiko Kawate and Norihiko Ikeda",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.5761/atcs.oa.17-00094",
    language = "English",
    volume = "24",
    pages = "73--80",
    journal = "Annals of Thoracic and Cardiovascular Surgery",
    issn = "1341-1098",
    publisher = "Japanese Association for Coronary Artery Surgery",
    number = "2",

    }

    TY - JOUR

    T1 - Cost-benefit performance simulation of robot-assisted thoracic surgery as required for financial viability under the 2016 revised reimbursement paradigm of the japanese national health insurance system

    AU - Kajiwara, Naohiro

    AU - Kato, Yasufumi

    AU - Hagiwara, Masaru

    AU - Kakihana, Masatoshi

    AU - Ohira, Tatsuo

    AU - Kawate, Norihiko

    AU - Ikeda, Norihiko

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - Purpose: To discuss the cost–benefit performance (CBP) and establish a medical fee system for robotic-assisted thoracic surgery (RATS) under the Japanese National Health Insurance System (JNHIS), which is a system not yet firmly established. Methods: All management steps for RATS are identical, such as preoperative and postoperative management. This study examines the CBP based on medical fees of RATS under the JNHIS introduced in 2016. Results: Robotic-assisted laparoscopic prostatectomy (RALP) and robotic-assisted partial nephrectomy (RAPN) now receive insurance reimbursement under the category of use of support devices for endoscopic surgery ($5420 and $3485, respectively). If the same standard amount were to be applied to RATS, institutions would need to perform at least 150 or 300 procedures thoracic operation per year to show a positive CBP ($317 per procedure as same of RALP and $130 per procedure as same of RAPN, respectively). Conclusion: Robotic surgery in some areas receives insurance reimbursement for its “supportive” use for endoscopic surgery as for RALP and RAPN. However, at present, it is necessary to perform da Vinci Surgical System Si (dVSi) surgery at least 150–300 times in a year in a given institution to prevent a deficit in income.

    AB - Purpose: To discuss the cost–benefit performance (CBP) and establish a medical fee system for robotic-assisted thoracic surgery (RATS) under the Japanese National Health Insurance System (JNHIS), which is a system not yet firmly established. Methods: All management steps for RATS are identical, such as preoperative and postoperative management. This study examines the CBP based on medical fees of RATS under the JNHIS introduced in 2016. Results: Robotic-assisted laparoscopic prostatectomy (RALP) and robotic-assisted partial nephrectomy (RAPN) now receive insurance reimbursement under the category of use of support devices for endoscopic surgery ($5420 and $3485, respectively). If the same standard amount were to be applied to RATS, institutions would need to perform at least 150 or 300 procedures thoracic operation per year to show a positive CBP ($317 per procedure as same of RALP and $130 per procedure as same of RAPN, respectively). Conclusion: Robotic surgery in some areas receives insurance reimbursement for its “supportive” use for endoscopic surgery as for RALP and RAPN. However, at present, it is necessary to perform da Vinci Surgical System Si (dVSi) surgery at least 150–300 times in a year in a given institution to prevent a deficit in income.

    KW - Cost-Benefit performance

    KW - Da Vinci Surgical System

    KW - Japanese National Health Insurance System

    KW - Robot-assisted thoracic surgery

    UR - http://www.scopus.com/inward/record.url?scp=85045832800&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85045832800&partnerID=8YFLogxK

    U2 - 10.5761/atcs.oa.17-00094

    DO - 10.5761/atcs.oa.17-00094

    M3 - Article

    VL - 24

    SP - 73

    EP - 80

    JO - Annals of Thoracic and Cardiovascular Surgery

    JF - Annals of Thoracic and Cardiovascular Surgery

    SN - 1341-1098

    IS - 2

    ER -